<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000572249">
  <TermName>Zinecard</TermName>
  <TermPronunciation>(ZIH-neh-kard)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug that contains the active ingredient dexrazoxane and is used to reduce heart damage in women who are receiving doxorubicin for breast cancer that has spread to other parts of the body. Zinecard is a type of cardioprotective agent, a type of chemoprotective agent, and a type of topoisomerase inhibitor.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000720791" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Zinecard&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000720790" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Zinecard&quot;" language="es" id="_4"/>
  <SpanishTermName>Zinecard</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento que contiene el principio activo dexrazoxano y se usa para reducir el da침o en el coraz칩n de mujeres que reciben doxorrubicina para un c치ncer de mama que se disemin칩 a otras partes del cuerpo. Zinecard es un tipo de cardioprotector, de quimioprotector y de inhibidor de la topoisomerasa.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2007-10-05</DateFirstPublished>
  <DateLastModified>2021-03-26</DateLastModified>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000570125" url="/about-cancer/treatment/drugs/dexrazoxanehydrochloride">Dexrazoxane Hydrochloride</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
